Polycythemia
Polycythemia is characterized by red blood cell count, hemoglobin, hematocrit and total blood volume significantly exceeding normal levels. In childhood, hemoglobin exceeds 180g/L (16g/dl), hematocrit is greater than 55% and the absolute value of red blood cell volume per kilogram of body weight exceeds 35ml. Relative erythrocytosis caused by blood concentration due to acute dehydration or burns can be excluded, and the disease can be diagnosed. This disease can be divided into two categories: primary and secondary. Primary is true polycythemia; secondary is mainly caused by tissue hypoxia.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Adults -
Related symptoms:
Dizziness fatigue forgetfulness itchy skin double vision -
Concurrent disease:
Relative erythrocytosis Secondary erythrocytosis Hereditary xerocytosis Stomatocytosis Hereditary elliptocytosis
Related Drugs
Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Chengdu Beite Denuo Pharmaceutical Co., Ltd.
Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Yaopharma Co., Ltd.
Homoharringtonine
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Homoharringtonine
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Beijing Xiehe Pharmaceutical Co., Ltd.
Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:
Harbin Pharm. Group Sanjing Pharmaceutical Co., Ltd.
Busulfan Tablets
Indication: It is mainly used in the chronic phase of chronic myeloid leukemia, and has poor effects on patients lacking the Philadelphia chromosome Ph1. It can also be used to treat chronic myeloproliferative diseases such as essential thrombocythemia and polycythemia vera.
Busulfan Tablets
Indication: It is used for chronic myeloid leukemia, and is also effective for polycythemia vera, chronic lymphocytic leukemia, and lymphoma.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Busulfan Tablets
Indication: It is used for chronic myeloid leukemia, and is also effective for polycythemia vera, chronic lymphocytic leukemia, and lymphoma.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Related Ingredients